InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.42
(
-0.20%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,089.49
(
0.15%
)
Brent Oil
74.26
(
-0.09%
)
Bitcoin
62,649.15
(
-0.48%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 138
Posts 23710
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: None

Wednesday, 12/06/2017 10:33:16 PM

Wednesday, December 06, 2017 10:33:16 PM

Post# of 23979
Watch IPIX tomorrow!!!

Formal collaboration with pharmaceutical companies that have expressed an interest in partnering Brilacidin-OM may well assist further with expediting the drug candidate’s development timetable. Some of these partnering conversations have matured to the point of potentially structuring mutually beneficial licensing agreements, pending the final Phase 2 study results.




http://www.ipharminc.com/press-release/2017/11/16/innovation-pharmaceuticals-offers-perspectives-on-brilacidin-as-a-potential-preventative-treatment-for-oral-mucositis-in-head-and-neck-cancer-patients

Good luck and GOD bless,

George
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up